Foghorn Therapeutics Balance Sheet (2019-2026) | FHTX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter)	125.17M	57.84M	101.14M	213.65M	61.21M	87.60M	52.21M	50.64M	57.70M	70.31M	80.34M	79.25M	138.95M	57.68M	55.45M	61.03M	72.57M	89.33M	80.88M	87.66M
Short-term Investments (Quarter)						0.03M											1.25M	1.25M	1.25M	1.25M
Cash & Current Investments (Quarter)	125.17M	57.84M	101.14M	213.65M	61.21M	87.63M	52.21M	50.64M	57.70M	70.31M	80.34M	79.25M	138.95M	57.68M	55.45M	61.03M	73.82M	90.58M	82.13M	88.91M
Receivables - Other (Quarter)			300.00M
Prepaid Assets (Quarter)	3.40M	3.11M	5.27M	5.09M	5.34M	4.24M	5.60M	4.73M	6.18M	5.55M	6.12M	4.86M	4.44M	3.84M	5.85M	4.83M	3.93M	2.59M	3.09M	3.18M
Current Assets (Quarter)	144.67M	123.95M	459.56M	429.82M	400.07M	377.76M	351.40M	320.70M	290.49M	265.44M	240.18M	211.52M	289.62M	271.23M	249.60M	225.42M	203.84M	184.12M	163.24M	188.06M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	19.00M	18.35M	17.56M	16.94M	16.46M	15.94M	15.31M	15.22M	14.61M	13.79M	12.96M	12.19M	10.76M	10.51M	9.96M	10.35M	9.51M	8.66M	1.92M	1.71M
Other Non-Current Assets (Quarter)	1.73M	1.73M	1.73M	1.73M	2.38M	1.71M	2.38M	1.71M	1.71M	1.71M	1.71M	1.05M	1.71M	1.71M	1.71M	0.02M	2.00M	0.01M	0.00M	2.00M
Non-Current Assets (Quarter)	63.85M	62.12M	60.21M	58.48M	56.83M	56.17M	53.48M	52.18M	49.08M	47.98M	45.73M	43.48M	38.96M	37.14M	34.38M	33.27M	22.39M	20.84M	34.87M	34.10M
Assets (Quarter)	208.53M	186.07M	519.77M	488.31M	456.90M	433.93M	404.88M	372.88M	339.58M	313.42M	285.92M	255.00M	328.58M	308.37M	283.98M	258.69M	226.24M	204.96M	198.10M	222.17M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	3.41M	3.82M	9.56M	5.07M	8.10M	5.26M	5.41M	7.29M	6.93M	8.80M	6.26M	5.63M	4.81M	3.45M	3.79M	4.07M	8.56M	3.21M	4.27M	6.92M
Payables (Quarter)	3.41M	3.82M	9.56M	5.07M	8.10M	5.26M	5.41M	7.29M	6.93M	8.80M	6.26M	5.63M	4.81M	3.45M	3.79M	4.07M	8.56M	3.21M	4.27M	6.92M
Accumulated Expenses (Quarter)	5.15M		9.56M	7.01M	8.10M	10.12M	11.00M	8.83M	8.14M	8.80M	9.11M	6.26M	6.45M	11.22M	8.53M	6.45M	8.56M	9.82M	11.36M	6.92M
Other Accumulated Expenses (Quarter)		0.11M	0.39M	0.23M	0.27M	0.32M	0.32M	0.14M	0.09M	0.30M	0.04M		0.24M	0.21M	0.00M	0.53M	0.39M	0.40M	0.40M	0.44M
Short term Debt (Quarter)
Current Leases (Quarter)	6.84M	6.99M	6.99M	6.10M	5.67M	6.67M	5.97M	6.35M	7.67M	8.37M	8.52M	8.67M	9.07M	8.77M	9.07M	9.11M	6.18M	6.75M	0.92M	1.86M
Current Deferred Revenue (Quarter)	1.90M	15.00M	337.80M	30.06M	30.57M	33.16M	32.82M	33.33M	33.90M	337.80M	34.55M	31.50M	31.23M	33.38M	45.61M	51.67M	59.72M	65.30M	43.19M	52.30M
Total Current Liabilities (Quarter)	16.41M	19.30M	48.69M	48.24M	47.97M	55.21M	55.20M	55.80M	56.64M	52.01M	58.44M	52.06M	50.87M	56.82M	66.99M	71.31M	77.79M	85.09M	59.74M	64.40M
Non-Current Liabilities
Capital Leases (Quarter)	0.20M
Non-Current Debt (Quarter)
Non-Current Deffered Revenue (Quarter)	1.90M	12.69M	322.73M	317.07M	312.07M	307.84M	304.00M	298.18M	292.02M	280.09M	268.12M	266.11M	259.50M	249.53M	234.46M	222.44M	206.83M	193.10M	205.96M	193.59M
Preferred Stock Liabilities (Quarter)
Operating Leases (Quarter)	61.64M	60.01M	58.33M	50.48M	49.14M	46.50M	51.51M	43.49M	40.27M	38.71M	36.55M	34.31M	28.06M	30.30M	37.13M	25.74M	23.70M	15.77M	40.35M	40.13M
Other Non-Current Liabilities (Quarter)		0.17M	0.14M	0.12M	0.09M	0.06M	0.03M									0.86M	0.76M	0.66M	0.56M	0.45M
Total Non-Current Liabilities (Quarter)		104.92M	422.76M	415.79M	409.18M	409.55M	404.74M	397.47M	388.93M	370.81M	363.11M				329.51M	319.49M	302.14M	293.96M	306.05M	298.12M
Total Liabilities (Quarter)	104.34M	105.09M	422.90M	415.90M	409.27M	409.61M	404.77M	397.47M	388.93M	370.81M	363.11M	352.49M	342.91M	336.66M	329.51M	320.34M	302.89M	294.62M	306.60M	298.57M
Shareholder's Equity
Total Debt (Quarter)
Common Equity (Quarter)	104.19M	80.98M	96.87M	72.40M	47.63M	24.32M	0.11M	-24.59M	-49.35M	-57.39M	-77.19M	-97.49M	-14.32M	-28.29M	-45.53M	-61.65M	-76.66M	-89.66M	-108.50M	-76.41M
Shareholder's Equity (Quarter)	104.19M	80.98M	96.87M	72.40M	47.63M	24.32M	0.11M	-24.59M	-49.35M	-57.39M	-77.19M	-97.49M	-14.32M	-28.29M	-45.53M	-61.65M	-76.66M	-89.66M	-108.50M	-76.41M
Liabilities and Shareholders Equity (Quarter)	208.53M	186.07M	519.77M	488.31M	456.90M	433.93M	404.88M	372.88M	339.58M	313.42M	285.92M	255.00M	328.58M	308.37M	283.98M	258.69M	226.24M	204.96M	198.10M	222.17M
Retained Earnings (Quarter)	-209.03M	-235.10M	-264.26M	-1.19M	-3.19M	-344.25M	-3.99M	-2.87M	-433.10M	-1.89M	-471.56M	-496.60M	-519.56M	-538.70M	-558.18M	-577.02M	-595.00M	-610.80M	-632.47M	-652.30M
Treasury Shares (Quarter)

Research Tools

Developers

Foghorn Therapeutics Balance Sheet (2019-2026) | FHTX

Research Tools

Developers

Foghorn Therapeutics Balance Sheet (2019-2026) | FHTX

Create an account

Sign In

Reset Password